Download Report

With the advent of lateral flow assays, the testing has been brought away from the
laboratory and closer to the patient. One of the major benefit of later flow assay
testing is that it leads to early diagnosis, treatment and monitoring of health
conditions. The healthcare industry has entered the era of rapid diagnostics, in which
test results are almost instantaneous and accurate. Moreover, complex and costly
equipment is not used in the lateral flow assays. Lateral flow assays uses
immunoassay technology through a combination of antibodies colored nanoparticles
and nitrocellulose membranes to present test results that can be visually interpreted.
One of the most popular example of lateral flow assay testing is the pregnancy test.
The global lateral flow assays market is slated to touch a value of about US$ 7,900
Mn in the year 2022 and grow at a robust CAGR during the assessment period.
Read Report Overview @ https://www.persistencemarketresearch.com/marketresearch/lateral-flow-assays-market.asp
As per the forecast of Persistence Market Research, the digital/mobile readers
product type segment is slated to touch a value of nearly US$ 2,250 Mn in the year
2022. This represents a robust CAGR growth during the assessment period of 20172022. The digital/mobile readers product type segment is estimated to account for
more than one-fourth of the revenue share of the product type segment by the year
2017 and is forecasted to gain market share by 2022 over 2017.As per the forecast of
Persistence Market Research, the diagnostic laboratories segment will reach a value
of about US$ 1,200 Mn in the year 2017. This represents a robust CAGR growth
during the forecast period. The diagnostic laboratories segment is forecasted to
account for more than one-fifth of the total revenue share of the end-user segment by
the end of the year 2017 and is expected to lose in market share by 2022 as compared
with the year 2017.
As per the forecast of Persistence Market Research, the cardiac marker testing
application type segment is slated to reach a value of nearly US$ 920 Mn in 2022.
The cardiac marker testing application type segment is expected to gain market share
by the end of the year 2022. The largest share is contributed by the North America
region in the cardiac marker testing application type segment. Persistence Market
Research forecasts the sandwich assays technology type segment to exhibit a
compound annual growth rate (CAGR) of about 7% from 2017 to 2022.
The report has also included the profiles of some of the leading companies in the
lateral flow assays market like Siemens Healthineers, Danaher Corporation, Thermo
Fisher Scientific, Inc., Dickinson and Company, Abbott Laboratories, Hologic Inc.,
Alere Inc., Johnson and Johnson, Becton, PerkinElmer, Inc., bioMerieux S.A,
QIAGEN N.V. and Bio-Rad Laboratories Inc.
Request Sample Report @
https://www.persistencemarketresearch.com/samples/18613
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research
model is a unique collaboration of data analytics and market research methodology to
help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a
multi-disciplinary approach. At PMR, we unite various data streams from multidimensional sources. By deploying real-time data collection, big data, and customer
experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA,Canada Toll Free: 800-961-0353
Email: [email protected]
Web: https://www.persistencemarketresearch.com/